Jördens, M.S.; Wittig, L.; Heinrichs, L.; Keitel, V.; Schulze-Hagen, M.; Antoch, G.; Knoefel, W.T.; Fluegen, G.; Luedde, T.; Loberg, C.;
et al. Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment. J. Clin. Med. 2021, 10, 4340.
https://doi.org/10.3390/jcm10194340
AMA Style
Jördens MS, Wittig L, Heinrichs L, Keitel V, Schulze-Hagen M, Antoch G, Knoefel WT, Fluegen G, Luedde T, Loberg C,
et al. Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment. Journal of Clinical Medicine. 2021; 10(19):4340.
https://doi.org/10.3390/jcm10194340
Chicago/Turabian Style
Jördens, Markus S., Linda Wittig, Lisa Heinrichs, Verena Keitel, Maximilian Schulze-Hagen, Gerald Antoch, Wolfram T. Knoefel, Georg Fluegen, Tom Luedde, Christina Loberg,
and et al. 2021. "Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment" Journal of Clinical Medicine 10, no. 19: 4340.
https://doi.org/10.3390/jcm10194340
APA Style
Jördens, M. S., Wittig, L., Heinrichs, L., Keitel, V., Schulze-Hagen, M., Antoch, G., Knoefel, W. T., Fluegen, G., Luedde, T., Loberg, C., Roderburg, C., & Loosen, S. H.
(2021). Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment. Journal of Clinical Medicine, 10(19), 4340.
https://doi.org/10.3390/jcm10194340